Cefepime-dextrose 2 GM/50 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26F9KS6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,166
Award facts
- Contract value 100% obligated
- $11,166.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Cefepime-Dextrose 2 GM/50 MLS, a broad-spectrum antibiotic commonly used in acute care settings. This competitively awarded, firm fixed-price delivery order has a ceiling value of $11,166.05 and is scheduled for completion by January 13, 2026. The contract will be performed at the awardee's location in Conshohocken, Pennsylvania. This order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is well-positioned to fulfill this order given its extensive federal procurement experience and established relationships with DLA. As a subsidiary of Cencora, Inc., the company leverages the parent company's significant IDC to supply a broad range of pharmaceutical products, medical supplies, and specialty medications to support Defense Health Agency operations and other federal healthcare systems. The non-set-aside designation indicates this award was made through open competition, demonstrating the company's competitive capabilities in meeting federal medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26F9KS6?
SPE2DR26F9KS6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F9KS6 worth?
The government has obligated $11,166 on SPE2DR26F9KS6.
Is contract SPE2DR26F9KS6 an order under another contract?
Yes. SPE2DR26F9KS6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KS6 competed?
The extent of competition for SPE2DR26F9KS6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award